SRL
NVS icon

Scientech Research LLC’s Novartis NVS Stock Holding History

Scientech Research LLC’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$206K Buy
+1,315
New +$197K 0.17% 158
2025
Q3 		– Sell
-4,568
Closed -$553K – 762
2025
Q2 		$553K Buy
+4,568
New +$515K 0.14% 309

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Scientech Research LLC's NVS Position: Q2 2026 in Review

Scientech Research LLC opened a new position in Novartis (NVS) in Q2 2026: 1,315 shares worth $206K. The stake represents 0.17% of the portfolio and ranks #158 among its holdings. This is a return to the name: Scientech Research LLC previously reported a position in NVS as recently as Q2 2025.

Scientech Research LLC first reported a position in NVS in Q2 2025 and has held it in 2 quarters since. The position peaked at $553K in Q2 2025. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Scientech Research LLC held 1,315 shares of Novartis worth $206K as of Q2 2026.
  • Novartis was a new Scientech Research LLC position in Q2 2026.
  • Novartis made up 0.17% of Scientech Research LLC's portfolio in Q2 2026, its #158 holding.
  • Scientech Research LLC first reported a position in Novartis in Q2 2025 and has held it in 2 quarters since.
  • Scientech Research LLC's Novartis position peaked at $553K in Q2 2025.
  • 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Scientech Research LLC's 13F filing for Q2 2026, filed 14 Aug 2026.